NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 619 / 982

  1. Toward an Account of Relational Autonomy in Healthcare and Treatment Settings2016 · Crossref
  2. Toward the Smarter Use of Smart Drugs2016 · OpenAlex
  3. Towards a cognitive neuroscience of self-awareness2016 · OpenAlex
  4. Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications2016 · OpenAlex
  5. Trade law and alcohol regulation: what role for a global Alcohol Marketing Code?2016 · Crossref
  6. Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis2016 · OpenAlex
  7. Trafficking of Plasmodium Falciparum Proteins: A Novel Anti-Malaria Drug Target?2016 · Crossref
  8. Training and Practices of Cannabis Dispensary Staff2016 · OpenAlex
  9. Trajectories of cannabis use disorder: risk factors, clinical characteristics and outcomes2016 · Crossref
  10. Trajectories of drinking urges and the initiation of abstinence during cognitive–behavioral alcohol treatment2016 · Crossref
  11. Trajectories of Drug Abuse and Addiction Development Among FSU Immigrant Drug Users in Israel2016 · Crossref
  12. Transactional Sex among Noninjecting Illicit Drug Users: Implications for HIV Transmission2016 · Crossref
  13. Transcriptome modulation during host shift is driven by secondary metabolites in desertDrosophila2016 · Crossref
  14. Transformation and Sorption of Illicit Drug Biomarkers in Sewer Systems: Understanding the Role of Suspended Solids in Raw Wastewater2016 · OpenAlex
  15. Transition to and Away from Injecting Drug Use among Young Drug Users in Tehran, Iran: A Qualitative Study2016 · OpenAlex
  16. Trauma in Veterans With Substance Use Disorder: Similar Treatment Need Among Urban and Rural Residents2016 · Crossref
  17. Traversing the triangulum: the intersection of tobacco, legalised marijuana and electronic vaporisers in Denver, Colorado: Table 12016 · OpenAlex
  18. Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy2016 · OpenAlex
  19. Treatment for Anhedonia: A Neuroscience Driven Approach2016 · OpenAlex
  20. Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol2016 · OpenAlex
  21. Treatment of Alcohol Use Disorder in Patients with Alcoholic Liver Disease2016 · OpenAlex
  22. Treatment of an Older Adult With Borderline Personality Disorder and Prescription Opioid Abuse2016 · Crossref
  23. Treatment of anxiety and depression: medicinal plants in retrospect2016 · OpenAlex
  24. Treatment of Cannabis Use Disorder: Current Science and Future Outlook2016 · OpenAlex
  25. Treatment of opioid use disorder in an innovative community-based setting after multiple treatment attempts in a woman with untreated HIV2016 · Crossref
  26. Treatment of Opioid-Use Disorders2016 · OpenAlex
  27. Treatment Seeking for Alcohol Use Disorders: Treatment Gap or Adequate Self-Selection?2016 · OpenAlex
  28. Treatment Utilization Among Adolescent Substance Users: Findings from the 2002 to 2013 National Survey on Drug Use and Health2016 · Crossref
  29. Treatment utilization among persons with opioid use disorder in the United States.2016 · PubMed
  30. Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics2016 · OpenAlex
  31. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology2016 · OpenAlex
  32. Trend in alcohol use in Australia over 13 years: has there been a trend reversal?2016 · OpenAlex
  33. Trends in bidi and cigarette smoking in India from 1998 to 2015, by age, gender and education2016 · OpenAlex
  34. Trends in cannabis use disorders among racial/ethnic population groups in the United States2016 · OpenAlex
  35. Troubled families and individualised solutions: an institutional discourse analysis of alcohol and drug treatment practices involving affected others2016 · Crossref
  36. Tryptophan Biochemistry: Structural, Nutritional, Metabolic, and Medical Aspects in Humans2016 · OpenAlex
  37. Tryptophan for the sleeping disorder and mental symptom of new-type drug dependence2016 · OpenAlex
  38. Turning the Tide or Riptide? The Changing Opioid Epidemic2016 · OpenAlex
  39. Twenty-One Cases Involving Alpha-Pyrrolidinovalerophenone (α-PVP)2016 · OpenAlex
  40. Twenty‐five years of prescription opioid use in Australia: a whole‐of‐population analysis using pharmaceutical claims2016 · OpenAlex
  41. Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses2016 · OpenAlex
  42. Two-year trends and predictors of e-cigarette use in 27 European Union member states2016 · OpenAlex
  43. Type and timing of adverse childhood experiences differentially affect severity of PTSD, dissociative and depressive symptoms in adult inpatients2016 · OpenAlex
  44. Type of opioid dependence among patients seeking opioid substitution treatment: are there differences in background and severity of problems?2016 · OpenAlex
  45. Typology of I nternet gaming disorder and its clinical implications2016 · OpenAlex
  46. Ultrafast Screening of Synthetic Cannabinoids and Synthetic Cathinones in Urine by RapidFire-Tandem Mass Spectrometry2016 · OpenAlex
  47. Under-reporting of Risky Drug Use Among Primary Care Patients in Federally Qualified Health Centers2016 · Crossref
  48. Understanding and learning from the diversification of cannabis supply laws2016 · OpenAlex
  49. Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico2016 · OpenAlex
  50. Understanding Student Drinking Patterns2016 · Crossref
  51. Understanding the Life Histories of Pregnant-Involved Young Aboriginal Women With Substance Use Experiences in Three Canadian Cities2016 · Crossref
  52. Understanding the Subjective Experience of Medication Adherence for Older Urban African Americans With Type 2 Diabetes and a History of Illicit Drug Addiction2016 · Crossref
  53. UNGASS 2016 in Comparative Perspective: Improving the Prospects for Success2016 · Crossref
  54. UNGASS 2016: Prospects for Treaty Reform and UN System-Wide Coherence on Drug Policy2016 · Crossref
  55. Unintentional Pediatric Exposures to Marijuana in Colorado, 2009-20152016 · OpenAlex
  56. Unique and Overlapping Symptoms in Schizophrenia Spectrum and Dissociative Disorders in Relation to Models of Psychopathology: A Systematic Review2016 · OpenAlex
  57. Up-regulation of serotonin receptor 2B mRNA and protein in the peri-infarcted area of aged rats and stroke patients2016 · OpenAlex
  58. Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use.2016 · PubMed
  59. Update on Performance in Tobacco Control: A Longitudinal Analysis of the Impact of Tobacco Control Policy and the US Adult Smoking Rate, 2011-20132016 · Crossref
  60. Update on the Pharmacology and Legal Status of Kratom2016 · Crossref
  61. Updated Clinical Guidelines for Diagnosing Fetal Alcohol Spectrum Disorders2016 · OpenAlex
  62. Urban landscapes of adolescent substance use2016 · Crossref
  63. Urban Young Adults’ Adaptive Functioning2016 · Crossref
  64. Urinary excretion study following consumption of various poppy seed products and investigation of the new potential street heroin marker ATM4G2016 · Crossref
  65. Urine ethanol concentration and alcohol hangover severity2016 · OpenAlex
  66. Use of alcohol and other drugs among male university students and its meanings2016 · OpenAlex
  67. Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia2016 · Crossref
  68. Use of cannabis components in the treatment of mental disorders2016 · Crossref
  69. Use of Carnosine for Oxidative Stress Reduction in Different Pathologies2016 · OpenAlex
  70. Use of finger‐prick dried blood spots (fpDBS) and capillary electrophoresis for carbohydrate deficient transferrin (CDT) screening in forensic toxicology2016 · Crossref
  71. Use of Marijuana for Medical Purposes Among Adults in the United States2016 · OpenAlex
  72. Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method.2016 · PubMed
  73. Use of novel psychoactive substances by inpatients on general adult psychiatric wards2016 · Crossref
  74. Use of psychoactive substances, body image and characteristics of personality traits in bodybuilders2016 · Crossref
  75. Use of Psychotropic Drug Urine Test Strips in Opiate Maintenance Therapy: A Clinical Assessment of its Advantages2016 · Crossref
  76. User Preferences for Content, Features, and Style for an App to Reduce Harmful Drinking in Young Adults: Analysis of User Feedback in App Stores and Focus Group Interviews2016 · OpenAlex
  77. Using Bayes factors for testing hypotheses about intervention effectiveness in addictions research2016 · OpenAlex
  78. Using evolutionary tools to search for novel psychoactive plants2016 · Crossref
  79. Using Humor in Treatment of Substance Use Disorders: Worthy of Further Investigation2016 · Crossref
  80. Using respondent-driven sampling (RDS) to recruit illegal poly-substance users in Cape Town, South Africa: implications and future directions2016 · OpenAlex
  81. Using the Personality Assessment Inventory Antisocial and Borderline Features Scales to Predict Behavior Change: A Multisite Longitudinal Study of Youthful Offenders2016 · Crossref
  82. Uso de drogas injetáveis entre mulheres na Região Metropolitana de Santos, São Paulo, Brasil2016 · OpenAlex
  83. Uso ritualístico da ayahuasca : percursos terapêuticos, saúde e espiritualidade2016 · OpenAlex
  84. Usual Modes of Marijuana Consumption Among High School Students in Colorado2016 · OpenAlex
  85. Utility of Machine-Learning Approaches to Identify Behavioral Markers for Substance Use Disorders: Impulsivity Dimensions as Predictors of Current Cocaine Dependence2016 · OpenAlex
  86. UTILIZATION OF AREN (Arenga pinnata Merr.) SAWMILLING WASTE FOR EDIBLE MUSHROOM CULTIVATION MEDIA2016 · Crossref
  87. Utilizing a train-the-trainer model for multi-site naloxone distribution programs2016 · OpenAlex
  88. Vaccenic acid suppresses intestinal inflammation by increasing anandamide and related N-acylethanolamines in the JCR:LA-cp rat2016 · OpenAlex
  89. Vagus Nerve Stimulation Enhances Extinction of Conditioned Fear in Rats and Modulates Arc Protein, CaMKII, and GluN2B-Containing NMDA Receptors in the Basolateral Amygdala2016 · OpenAlex
  90. Validated multi‐drug determination using liquid chromatography with tandem mass spectrometry for the evaluation of a commercial drug disposal product2016 · Crossref
  91. Validation of the Alcohol Use Disorders Identification Test in university students: AUDIT and AUDIT-C2016 · OpenAlex
  92. Validation of the French Version of the DSM-5 Yale Food Addiction Scale in a Nonclinical Sample2016 · OpenAlex
  93. Validation of the Polish version of the Penn Alcohol Craving Scale (PACS)2016 · Crossref
  94. Validity of the alcohol purchase task: a meta‐analysis2016 · Crossref
  95. Valproate, risperidone, and antibiotic levels2016 · Crossref
  96. Vanadium isotope ratio measurements in fruit-bodies of Amanita muscaria2016 · Crossref
  97. Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes2016 · OpenAlex
  98. Variation in Volatile Constituents and Eugenol Content of Five Important Betelvine (Piper betleL.) Landraces Exported from Eastern India2016 · OpenAlex
  99. VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease2016 · OpenAlex
  100. Ventral tegmental area glutamate neurons co-release GABA and promote positive reinforcement2016 · OpenAlex